Prognostic subgroups for citalopram response in the STAR*D trial

Journal of Clinical Psychiatry

Volumn 75, Issue 7, 2014, Pages 738-747

  Jakubovski, Ewgeni ^a   Bloch, Michael H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DSM-IV; EDUCATIONAL STATUS; EMPLOYMENT STATUS; GENERALIZED ANXIETY DISORDER; HAMILTON SCALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; OPEN STUDY; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; REMISSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANXIETY DISORDERS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84905218359     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08727     Document Type: Article

References (31)

1. Cuijpers P, van Straten A, Schuurmans J, et al. Psychotherapy for chronic major depression and dysthymia: a meta analysis. http://dare.ubvu.vu.nl/ handle/1871/16585. Updated 2009. Accessed April 7, 2014.
2. Cuijpers P, van Straten A, van Oppen P, et al. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? a meta-analysis of comparative studies. J Clin Psychiatry. 2008;69(11):1675-1685; quiz 1839-1841. PubMed
3. Marcus SC, Olfson M. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 2010;67(12):1265-1273. doi:10.101/ archgenpsychiatry.2010.151 PubMed
4. Taylor MJ, Freemantle N, Geddes JR, et al. Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and metaanalysis. Arch Gen Psychiatry. 2006;63(11):1217-1223. doi:10.101/archpsyc. 63.1.1217 PubMed (Pubitemid 44708080)
5. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed (Pubitemid 43050100)
6. Mulsant BH, Houck PR, Gildengers AG, et al. What is the optimal duration of a short-term antidepressant trial when treating geriatric depression? J Clin Psychopharmacol. 2006;26(2):113-120. doi:10.1097/01.jcp.020471.07214.94 PubMed (Pubitemid 43740333)
7. Andreescu C, Lenze EJ, Dew MA, et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry. 2007;190(4):344-349. doi:10.192/bjp.bp.106.027169 PubMed (Pubitemid 46580685)
8. WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ. 2000;78(4):413-426. PubMed
9. Weich S, Lewis G. Poverty, unemployment, and common mental disorders: population based cohort study. BMJ. 1998;317(7151):115-119. doi:10.136/bmj.317. 7151.15 PubMed (Pubitemid 28310618)
10. Lorant V, Deliège D, Eaton W, et al. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003;157(2):98-112. doi:10.1093/aje/kwf182 PubMed (Pubitemid 36077441)
11. Katz SJ, Kessler RC, Frank RG, et al. Mental health care use, morbidity, and socioeconomic status in the United States and Ontario. Inquiry. 1997;34(1):38-49. PubMed (Pubitemid 27203191)
12. Rush AJ, Fava M, Wisniewski SR, et al. STAR*D Investigators Group. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119-142. doi:10.1016/S0197-2456(03) 012-0 PubMed (Pubitemid 38230109)
13. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am. 2003;26(2):457-494, x. doi:10.1016/S0193-953X(02)0107-7 PubMed
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296. doi:10.1/j.204-8260.1967.tb0530.x PubMed
16. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58(8):787-794. doi:10.101/archpsyc.58.8.787 PubMed (Pubitemid 32717805)
17. Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Compr Psychiatry. 2001;42(3):175-189. doi:10.1053/comp.201.23126 PubMed (Pubitemid 32410920)
18. Rush AJ, Zimmerman M, Wisniewski SR, et al. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affect Disord. 2005;87(1):43-55. doi:10.1016/j.jad.205.03.05 PubMed (Pubitemid 40828202)
19. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and selfreport (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. doi:10.1016/S06-323(02)0186-8 PubMed (Pubitemid 37289444)
20. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73-82. doi:10.1017/ S032917030107 PubMed (Pubitemid 38139442)
21. Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the quick inventory of depressive symptomatology and the Hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry. 2006;59(6):493-501. doi:10.1016/j.biopsych.205.08.02 PubMed (Pubitemid 43320536)
22. Kraemer HC. Evaluating Medical Tests: Objective and Quantitative Guidelines. Thousand Oaks, CA: SAGE Publications, Inc; 1992:296.
23. Cohen J. Statistical Power Analysis for the Behavioral Sciences Second Edition. New York, NY: Routledge Academic; 1988.
24. Cook EF, Goldman L. Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis. J Chronic Dis. 1984;37(9-10):721-731. doi:10.1016/021-9681(84)9041-9 PubMed (Pubitemid 15180632)
25. Ronalds C, Creed F, Stone K, et al. Outcome of anxiety and depressive disorders in primary care. Br J Psychiatry. 1997;171(5):427-433. doi:10.192/bjp.171.5.427 PubMed (Pubitemid 27475839)
26. Viinamäki H, Haatainen K, Honkalampi K, et al. Which factors are important predictors of non-recovery from major depression? a 2-year prospective observational study. Nord J Psychiatry. 2006;60(5):410-416. doi:10.1080/0803948060937801 PubMed (Pubitemid 44575520)
27. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342-351. doi:10.176/api.ajp.207.061868 PubMed (Pubitemid 351704490)
28. Cohen A, Gilman SE, Houck PR, et al. Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol. 2009;44(4):272-277. doi:10.107/s0127-08-0436-8 PubMed
29. Gianaros PJ, Marsland AL, Sheu LK, et al. Inflammatory pathways link socioeconomic inequalities to white matter architecture. Cereb Cortex. 2013;23(9):2058-2071. doi:10.1093/cercor/bhs191 PubMed
30. Aro S, Aro H, Keskimäki I. Socio-economic mobility among patients with schizophrenia or major affective disorder: a 17-year retrospective follow-up. Br J Psychiatry. 1995;166(6):759-767. doi:10.192/bjp.16.6.759 PubMed
31. van der Lem R, van der Wee NJA, van Veen T, et al. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice. Psychother Psychosom. 2012;81(4):226-234. doi:10.159/030890 PubMed